Results 1 to 10 of about 10,876 (118)
Targeted therapy combined with local consolidative surgery for oligometastatic stage IVA lung adenocarcinoma with CCDC6-RET fusion: a case report [PDF]
Frontiers in OncologyBackgroundPrecision therapy for non-small cell lung cancer (NSCLC) has expanded to include rare driver genes. RET fusion is a rare target in lung cancer, and data on targeted therapy combined with local consolidation surgery in advanced patients with ...
Faxian Gao +11 more
doaj +2 more sources
Metastasis-directed radiation therapy may improve progression-free survival in patients with oligometastatic solid tumors [PDF]
Ca-A Cancer Journal for CliniciansPrintz C.
exaly +2 more sources
ESMO Gastrointestinal Oncology, 2023 Oligometastatic cancer is characterized by the presence of a restricted number of metastatic lesions extending beyond the primary tumor. Until recently, there was a significant lack of agreement concerning the precise definition and optimal treatment ...
T.E. Kroese +4 more
doaj +1 more source
Management of Oligometastatic Breast Cancer: An Expert Committee’s Opinion
Current Oncology, 2023 Patients with oligometastatic breast cancer (BC) are candidates of choice for metastasis-directed therapy (MDT). This paper summarizes the opinions of an expert committee about the management of oligometastatic BC.
Dominique Leblanc +8 more
doaj +1 more source
Role of PSMA PET-guided metastases-directed therapy in oligometastatic recurrent prostate cancer
Frontiers in Oncology, 2022 Oligometastatic prostate cancer (OMPC) has been proposed as an intermediary state between localised disease and widespread metastases, with varying definitions including 1, 3, or ≤5 visceral or bone metastasis.
Matthew Alberto +9 more
doaj +1 more source
Current Oncology, 2022 Metastatic hormone-sensitive prostate cancer (mHSPC) is usually categorized as high- or low-volume disease. This is relevant because low- and high-volume metastatic disease are associated with different outcomes, and thus management of the two forms ...
Elena Verzoni +12 more
doaj +1 more source
Annals of Urologic Oncology, 2022 Background The development of new metabolic diagnostic imaging PET is changing the history of metastatic prostate cancer (pCa), identifying situations of progression with a low disease burden; radiation treatment of metabolically active oligometastatic ...
Riccardo Vigna-Taglianti +11 more
doaj +1 more source
Clinical and Translational Radiation Oncology, 2020 Background: Bone metastases cause significant morbidity in patients with cancer, and radiation therapy (RT) is an effective treatment approach. Indications for more complex ablative techniques are emerging.
Erin F. Gillespie +15 more
doaj +1 more source
Outcome of lung oligometastatic patients treated with stereotactic body irradiation
Frontiers in Oncology, 2022 PurposeThe oligometastatic stage is an intermediate stage of cancer between the localized stage and polymetastatic stage. The prognosis of patients in this stage also appears to be intermediate.
Guillaume Virbel +8 more
doaj +1 more source
Frontiers in Oncology, 2022 The role of cytoreductive nephrectomy in patients with metastatic renal cell carcinoma is a subject of debate. We report a durable complete response in a 62-year-old man Jehovah’s Witness with metastatic clear cell renal cell carcinoma who received two ...
Tony Zibo Zhuang +19 more
doaj +1 more source